OQS
TARO

Occudo Quantitative Strategies’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Occudo Quantitative Strategies’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,561
Closed -$211K – 1383
2023
Q2 		$211K Buy
+5,561
New +$175K 0.02% 839

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Occudo Quantitative Strategies's TARO Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2023, closing a stake of 5,561 shares — an estimated $211K sold.

Occudo Quantitative Strategies first reported a position in TARO in Q2 2023 and held it in 1 quarter. The position peaked at $211K in Q2 2023. 82 funds tracked by Wall St. Rank hold TARO as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,561 Taro Pharmaceutical Industries Ltd. shares in Q3 2023, an estimated $211K.
  • Occudo Quantitative Strategies first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2023 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Taro Pharmaceutical Industries Ltd. position peaked at $211K in Q2 2023.
  • 82 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.